bioRxivMicrobiology
Identification of a Type IV CRISPR-Cas system located exclusively on IncHI1B/ IncFIB plasmids in Enterobacteriaceae
Abstract
During an investigation of CRISPR carriage in clinical, multi-drug resistant, Klebsiella pneumoniae, a novel CRISPR-Cas system (which we have designated Type IV-B) was detected on plasmids from two K. pneumoniae isolates from Egypt (isolated in 2002-2003) and a single K. pneumoniae isolate from the UK (isolated in 2017). Sequence analysis of other genomes available in GenBank revealed that this novel Type IV-B CRISPR-Cas system was present on 28 other plasmids from various Enterobacteriaceae hosts and was never found on the chromosome. Type IV-B is found exclusively on IncHI1B/IncFIB plasmids and is associated with multiple putative transposable elements. Type IV-B has a single repeat-spacer array (CRISPR1) upstream of the cas loci with some spacers matching regions of conjugal transfer genes of IncFIIK/IncFIB(K) plasmids suggesting a role in plasmid incompatibility. Expression of the cas loci was confirmed in available clinical isolates by RT-PCR; indicating the system is active. To our knowledge, this is the first report describing a new subtype within Type IV CRISPR-Cas systems exclusively associated with IncHI1B/IncFIB plasmids. ImportanceHere, we report the identification of a novel subtype of Type IV CRISPR-Cas that is expressed and exclusively carried by IncHI1B/IncFIB plasmids in Enterobacteriaceae, demonstrating unique evolutionarily juxtaposed connections between CRISPR-Cas and mobile genetic elements (MGEs). Type IV-B encodes a variety of spacers showing homology to DNA from various sources, including plasmid specific spacers and is therefore thought to provide specific immunity against plasmids of other incompatible groups (IncFIIK/IncFIB(K)). The relationship between Type IV-B CRISPR-Cas and MGEs that surround and interrupt the system is likely to promote rearrangement and be responsible for the observed variability of this type. Finally, the Type IV-B CRISPR-Cas is likely to co-operate with other cas loci within the bacterial host genome during spacer acquisition.
- organism: bacteria (other)
- research focus: host-pathogen & immune response
- approach: experimental assay
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Type IV CRISPR-Cas systems are highly diverse and involved in competition between plasmids
R. Pinilla-Redondo, D. Mayo-Munoz, … S. A. Shah·bioRxiv·Sep 24, 2019
- Type IV-A3 CRISPR-Cas systems drive inter-plasmid conflicts by acquiring spacers in trans
F. Benz, S. Camara-Wilpert, … R. Pinilla-Redondo·bioRxiv·Jun 23, 2023
- Genomic characterization of type I-E* CRISPR-Cas systems in Klebsiella pneumoniae: association of spacer diversity and antimicrobial resistance
Ankur Rao, Tawsif Ahmed Kazi, … Sulagna Basu·bioRxiv·Dec 3, 2025
- A Campylobacter integrative and conjugative element with a CRISPR-Cas9 system targeting competing plasmids: a history of plasmid warfare?
A. H. M. van Vliet, O. Charity, M. Reuter·bioRxiv·Jun 1, 2021
- CRISPR-Cas systems are widespread accessory elements across bacterial and archaeal plasmids
R. Pinilla-Redondo, J. Russel, … S. J. Soerensen·bioRxiv·Jun 4, 2021
- Co-occurrence of multiple CRISPRs and cas clusters suggests epistatic interactions
Aude G. Bernheim, David Bikard, … Eduardo P. C. Rocha·bioRxiv·Mar 30, 2019